Catalyst Wire Dossier Catalyst Wire Dossier

BIBV 308 SE

· Boehringer Ingelheim
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for BIBV 308 SE, covering 2014-08-22 to 2014-08-22. Get the full timeline:

Most recent: Clinical Trial Update: Relative Bioavailability and Tolerability of Two New Different Extended Release Capsules of BIBV 308 SE, Versus a Solution of BIBV 308 SE in Healthy Subjects [Phase 1]

See pricing